Study 7 of 9Melanotan II literatureeuropepmc · Case report2026
Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use.
This case report highlights a potential link between melanotan exposure and the development of primary melanomas in a patient with additional risk factors.
Where it sits
this study against the rest of the melanotan ii corpus3
Preclinical
6
Observational · this one
0
Open-label
0
Randomised
0
Reviews
Summary and findings
This paper reports on five primary melanomas in situ in a patient with a history of tanning bed use, melanotan exposure, and anabolic hormone use. The study highlights the potential associations between these factors and the development of melanoma. No therapeutic claims are made regarding melanotan exposure.
How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.n=12026
Elsewhere in the Melanotan II corpus
CAssociation of central α-klotho with dopaminergic and melanocortin receptors on feed intake regulation in chicken.europepmc · 2026 · Not reported in abstract.AnimalCLow dose systemic AAV-exendin-4 gene therapy for Prader-Willi syndrome and dietary obesity.europepmc · 2026 · Not reported in abstract.AnimalCMelanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for foodbiorxiv-preprint · 2022 · n=20 · Not reported in abstract.AnimalBChanges in Oral Mucosa Associated with Melanotan II Injections: A Case Report.PubMed · 2026 · Not reported in abstract.HumanDSemantic Scholar search for Melanotan IISemanticScholar—DBarbie drug identification: Not a child's play.PubMed · 2024 · 30% purity of Melanotan II.—